200 Solutions When You Are Highly Allergic and Sensitive to Fumes, Medicines, and Other Common Substances

Reactions may result from asthma, irritant-induced airway symptoms, allergic rhinitis, migraine, contact dermatitis, vocal-cord/inducible laryngeal obstruction, panic/autonomic responses, or idiopathic environmental intolerance (“multiple chemical sensitivity”). These conditions require different treatments.

There is no single medication or proven “detox” treatment for fragrance or chemical sensitivity.

The main strategy is to:

Leave significant exposures
Improve ventilation and clean your air
Identify and treat specific diagnoses
Develop a practical exposure plan.

1–20: Immediate Response and Emergency Safety

Move immediately into clean, fresh air.
Stop the spraying, painting, or chemical application if it is safe to do so.
Leave the building when breathing symptoms are substantial.
Call emergency services for severe breathing difficulty.
Call emergency services for blue lips, confusion, collapse, or fainting.
Use prescribed rescue asthma medication according to the patient’s action plan.
Use prescribed epinephrine for signs of anaphylaxis—not merely odor discomfort.
Call emergency services after using epinephrine.
Avoid re-entering the contaminated area prematurely.
Remove clothing saturated with paint or chemicals.
Place contaminated clothing in a sealed bag.
Wash exposed skin gently with soap and water.
Irrigate exposed eyes with clean lukewarm water for at least 15 minutes.
Remove contact lenses during eye irrigation when possible.
Do not induce vomiting after swallowing paint or solvent.
Do not use bleach, ammonia, or another chemical to “neutralize” fumes.
Contact Poison Control in the United States at 1-800-222-1222.
Obtain the product label or Safety Data Sheet for responders.
Monitor symptoms for several hours after a significant exposure.
Seek urgent assessment when symptoms continue despite leaving the area.

21–40: Identify What Is Actually Being Treated

Take a detailed history of each reaction.
Record the exact product involved.
Photograph product labels when safe.
Obtain the Safety Data Sheet for workplace products.
Record how quickly symptoms begin.
Record how long symptoms last.
Distinguish odor perception from physical contact with the substance.
Determine whether wheezing occurs.
Check for coughing or chest tightness.
Check for throat closing, voice change, or noisy inhalation.
Check for hives, swelling, or low blood pressure.
Check for nasal congestion, sneezing, or drainage.
Check for headaches, light sensitivity, or nausea.
Check for skin rashes after fragranced-product contact.
Compare symptoms at work, home, and outdoors.
Have a clinician assess for asthma.
Perform spirometry when clinically appropriate.
Consider peak-flow monitoring around suspected exposures.
Consider bronchial-provocation testing through a specialist when necessary.
Consider evaluation for inducible laryngeal obstruction.

41–60: Additional Diagnostic Steps

Evaluate persistent symptoms for allergic rhinitis.
Use allergy testing only when the history suggests an allergic trigger.
Recognize that ordinary fragrance reactions usually cannot be diagnosed by allergy blood tests.
Consider patch testing for suspected allergic contact dermatitis.
Evaluate recurrent headaches for migraine.
Evaluate dizziness for vestibular migraine when appropriate.
Assess for dysfunctional breathing or hyperventilation.
Assess panic symptoms without assuming that all symptoms are psychological.
Review medication adverse effects that may worsen dizziness or breathing.
Evaluate reflux when throat symptoms are recurrent.
Check for chronic sinus disease when indicated.
Consider occupational asthma if symptoms improve away from work.
Refer suspected occupational lung disease to occupational medicine.
Consider irritant-induced asthma after a major single exposure.
Evaluate persistent cough for alternative causes.
Consider cardiac causes of chest discomfort or breathlessness.
Consider anemia or thyroid disease when generalized symptoms persist.
Evaluate objective multisystem episodes for mast-cell disorders when clinically justified.
Avoid diagnosing mast-cell activation solely from fragrance intolerance.
Reassess the diagnosis when treatment for the presumed condition fails.

61–80: Remove or Reduce Emission Sources

Establish a fragrance-free household policy.
Stop using air freshener sprays.
Remove plug-in air fresheners.
Remove scented candles.
Avoid burning incense.
Switch to fragrance-free laundry detergent.
Stop using scented fabric softeners.
Avoid dryer sheets.
Choose fragrance-free soap and shampoo.
Use fragrance-free cleaning products.
Store paint outside occupied living areas.
Keep solvents in sealed original containers.
Remove leaking chemical containers.
Dispose of hazardous products through approved programs.
Select low-VOC or zero-VOC paint when feasible.
Remember that “low VOC” does not mean odorless or risk-free.
Prefer water-based products when suitable.
Avoid indoor spray painting.
Paint when the sensitive person can remain elsewhere.
Allow adequate curing and ventilation before reoccupancy.

81–100: Ventilation and Air Cleaning

Open exterior windows when outdoor air quality is acceptable.
Create cross-ventilation using windows on opposite sides.
Exhaust contaminated air directly outdoors.
Place a fan facing outward in a window near the source.
Avoid blowing contaminated air toward other occupied rooms.
Close doors between the work area and living areas.
Seal temporary gaps around the work zone when appropriate.
Turn off HVAC recirculation if it spreads fumes.
Use dedicated local exhaust during painting.
Follow the paint manufacturer’s ventilation instructions.
Continue ventilation after painting has ended.
Use outdoor-air ventilation rather than odor-masking products.
Use a properly sized air cleaner with substantial activated carbon for gases.
Understand that HEPA filters primarily remove particles, not solvent vapors.
Use HEPA filtration for dust or aerosol particles associated with renovation.
Replace saturated carbon filters as directed.
Maintain HVAC filters on schedule.
Avoid ionizers that generate ozone.
Do not use ozone generators in occupied spaces.
Have ventilation systems evaluated by a qualified professional when problems persist.

101–120: Respiratory Protection and Exposure Procedures

Do not rely on a cloth mask for solvent vapors.
Do not expect an N95 respirator to remove paint gases or VOCs.
Use respirators only as part of an appropriate safety program.
Select cartridges specifically approved for the relevant vapor.
Obtain medical clearance before occupational respirator use.
Perform fit testing for tight-fitting respirators.
Check the respirator seal every time it is worn.
Keep facial hair away from the respirator seal.
Establish a cartridge-change schedule.
Replace cartridges before breakthrough occurs.
Store respirator cartridges in airtight containers between uses.
Do not enter oxygen-deficient spaces with an air-purifying respirator.
Do not use consumer masks as a substitute for evacuation.
Use chemical-resistant gloves appropriate to the product.
Wear protective eyewear during painting or solvent handling.
Use disposable coveralls during major renovation work.
Wash hands before touching the face.
Shower after substantial occupational exposure.
Keep work shoes and clothing out of living spaces.
Obtain industrial-hygiene advice for complicated exposures.

121–140: Asthma and Lower-Airway Treatment

These treatments require an individualized medical plan.

Create a written asthma action plan.
Teach correct inhaler technique.
Use a spacer with a metered-dose inhaler when appropriate.
Keep prescribed rescue medication readily available.
Use an inhaled corticosteroid-containing regimen when indicated.
Take prescribed controller medication consistently.
Review adherence before escalating treatment.
Recheck inhaler technique at follow-up visits.
Treat exercise-induced bronchoconstriction appropriately.
Consider specialist-directed combination inhaler therapy.
Consider leukotriene-receptor treatment in selected patients.
Treat severe asthma through an asthma specialist.
Consider biologic therapy only for qualifying severe asthma.
Measure peak flow against the patient’s personal best.
Seek urgent care for falling peak flow with worsening symptoms.
Avoid routine oral corticosteroids unless medically indicated.
Use short oral corticosteroid courses only under clinician direction.
Avoid excessive rescue-inhaler use.
Control smoke, dust, and other coexisting asthma triggers.
Update the treatment plan after an emergency asthma episode.

141–160: Nose, Eyes, Skin, Throat, and Migraine Treatment

Use saline nasal spray for mild nasal irritation.
Consider sterile saline nasal irrigation.
Use distilled, sterile, or properly boiled and cooled water for irrigation.
Consider an intranasal corticosteroid for persistent rhinitis.
Consider a nasal antihistamine when medically appropriate.
Use oral antihistamines primarily for allergic symptoms—not solvent toxicity.
Prefer less-sedating antihistamines when appropriate.
Avoid prolonged use of decongestant nasal sprays.
Use preservative-free artificial tears for irritated eyes.
Apply cool compresses to irritated eyes.
Treat eyelid or eye inflammation through an eye-care professional.
Use fragrance-free moisturizers for skin-barrier protection.
Avoid the specific allergen identified by patch testing.
Treat contact dermatitis with clinician-recommended topical medication.
Avoid topical steroid overuse, especially on the face.
Obtain speech-language therapy for inducible laryngeal obstruction.
Practice prescribed laryngeal-control breathing.
Create a migraine prevention and rescue plan.
Reduce bright light and noise during odor-triggered migraine.
Use migraine-preventive medication when attacks are frequent.

161–180: Workplace, School, Healthcare, and Housing Accommodations

Request a fragrance-free workplace policy.
Ask coworkers to avoid perfumes and scented sprays.
Post neutral fragrance-free notices where appropriate.
Provide advance notice of painting or renovation.
Schedule painting when the area is unoccupied.
Temporarily relocate the affected person.
Offer remote work during renovation.
Move the workstation away from entrances or restrooms.
Improve outdoor-air delivery at the workstation.
Prevent air from loading docks or smoking areas entering the building.
Use enclosed rooms for fragranced activities when unavoidable.
Schedule healthcare visits early in the day when possible.
Ask medical offices to note fragrance sensitivity in the chart.
Request a low-odor waiting area.
Wait outdoors or in a vehicle when medically and logistically safe.
Request fragrance-free hotel rooms.
Confirm that lodging has not recently been painted.
Ask schools to restrict aerosol products near the student.
Develop a school health and emergency-response plan.
Consult disability or occupational specialists about reasonable accommodations.

181–200: Long-Term Symptom Management and Prevention

Keep a structured exposure-and-symptom diary.
Focus avoidance on reproducible triggers rather than every detectable odor.
Avoid becoming unnecessarily isolated.
Maintain safe physical activity within symptom limits.
Restore normal activities gradually after symptoms stabilize.
Use pulmonary rehabilitation when deconditioning is present.
Learn slow diaphragmatic breathing.
Treat dysfunctional breathing through respiratory physiotherapy.
Use cognitive behavioral therapy to improve coping when helpful.
Understand that psychological treatment does not mean symptoms are imaginary.
Treat coexisting anxiety or panic disorder.
Treat depression caused or worsened by functional limitations.
Maintain a regular sleep schedule.
Manage migraine-promoting sleep deprivation and skipped meals.
Stop smoking and vaping.
Avoid secondhand smoke.
Avoid unproven “detox,” chelation, or extreme supplement programs.
Avoid deliberately provoking severe reactions as self-treatment.
Carry a concise written emergency and medication plan.
Review the diagnosis, exposures, accommodations, and treatment response regularly.

Important Distinctions

Fragrances can aggravate asthma or migraine without being an IgE-mediated allergy.
Odor alone does not prove toxic exposure: some hazardous gases have little odor, while some noticeable odors occur below toxic concentrations.
Epinephrine is for probable anaphylaxis, such as breathing compromise plus hives, swelling, vomiting, or low blood pressure—not for isolated headache or odor aversion.
A HEPA filter does not reliably remove VOC gases. Activated carbon or other gas-phase media may help, but source removal and outdoor ventilation are more important.
Broad avoidance of all public spaces can worsen disability. Plans should balance safety, appropriate accommodations, and maintaining function.

References

U.S. Environmental Protection Agency. Volatile Organic Compounds’ Impact on Indoor Air Quality.
U.S. EPA. Guide to Air Cleaners in the Home.
CDC/NIOSH. Organic Vapor Cartridge Respirator Guidance and Respirator Selection.
Occupational Safety and Health Administration. Respiratory Protection Standard, 29 CFR 1910.134.
Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. Current report.
Wallace DV, Dykewicz MS, Oppenheimer J, Portnoy JM, Lang DM. Rhinitis 2020: A practice parameter update. J Allergy Clin Immunol. 2020;146:721–767.
American College of Medical Toxicology. Position statements and guidance concerning inhalational chemical exposures.
America’s Poison Centers. Poison Help: 1-800-222-1222.
CDC/NIOSH. Preventing Occupational Asthma and Work-Related Respiratory Disease.
U.S. Access Board. Indoor Environmental Quality and Fragrance-Related Accommodation Guidance.

100 Additional Measures for Reactions to Foods, Medicines, and Inactive Ingredients

These continue the prior list as 201–300. “Fillers” are more accurately called inactive ingredients or excipients, such as dyes, flavorings, preservatives, lactose, gelatin, polyethylene glycol (PEG), polysorbates, starches, and tablet binders.

Important: Food intolerance, medication side effects, poisoning, anxiety-related symptoms, and immune-mediated allergy are not interchangeable. Treatment should be based on the most likely mechanism rather than assuming every reaction is an allergy.

201–220: Immediate Reaction Safety

Stop eating or taking the suspected product when an acute reaction begins.
Do not intentionally re-dose the product to “confirm” a reaction.
Use prescribed epinephrine promptly for probable anaphylaxis.
Inject epinephrine into the outer mid-thigh according to the device instructions.
Call emergency services after epinephrine use.
Use a second epinephrine dose if symptoms persist or return and the emergency plan directs it.
Lie down with the legs elevated during anaphylaxis unless breathing is easier while sitting.
Do not suddenly stand or walk during anaphylaxis because blood pressure may collapse.
Place a vomiting or unconscious breathing person on their side.
Begin CPR if the person is unresponsive and not breathing normally.
Do not substitute an antihistamine for epinephrine in anaphylaxis.
Do not depend on an asthma inhaler to treat throat swelling or low blood pressure.
Seek emergency help for throat tightness, wheezing, faintness, or rapidly progressive swelling.
Seek urgent help for blistering, skin peeling, mouth sores, or eye sores after medication use.
Seek urgent care for fever, facial swelling, rash, and internal-organ symptoms after starting a medicine.
Seek urgent assessment for persistent vomiting, dehydration, or bloody stool after food exposure.
Contact Poison Control for overdose, dosing errors, or uncertain medication ingestion; in the U.S., call 1-800-222-1222.
Keep the food package, medicine container, and ingredient list for evaluation.
Record the amount consumed, route taken, and time symptoms began.
Obtain emergency observation after a serious reaction because symptoms can occasionally recur.

221–240: Determine the Reaction Mechanism

Obtain a detailed allergy history from an allergist or appropriately trained clinician.
Document the exact food, brand, medication, dose, formulation, and manufacturer.
Record every symptom rather than using only the term “reaction.”
Record how quickly symptoms began after exposure.
Record whether the patient had previously tolerated the substance.
Note cofactors such as exercise, alcohol, infection, menstruation, sleep loss, or NSAID use.
Distinguish immediate reactions occurring within minutes to several hours from delayed reactions.
Distinguish predictable medication side effects from immune-mediated allergy.
Distinguish food allergy from lactose, fructose, or other food intolerance.
Consider food poisoning when several people eating the same food become ill.
Consider celiac disease when gluten causes chronic gastrointestinal or nutritional symptoms.
Test for celiac disease before starting a strict gluten-free diet when medically feasible.
Consider eosinophilic gastrointestinal disease when swallowing difficulty or food impaction occurs.
Consider oral-allergy/pollen-food syndrome when raw fruits or vegetables cause localized mouth itching.
Consider alpha-gal syndrome after delayed reactions to mammalian meat or gelatin.
Consider food-dependent exercise-induced anaphylaxis when food is tolerated unless followed by exercise.
Consider nonallergic medication reactions, including direct histamine release or pharmacologic intolerance.
Evaluate recurrent objective multisystem episodes for mast-cell disorders when clinically justified.
Do not diagnose mast-cell activation solely from nonspecific reactions to many unrelated products.
Reassess the working diagnosis when avoidance and treatment do not produce the expected benefit.

241–260: Evidence-Based Testing and Challenge Procedures

Use skin-prick testing only when guided by a compatible clinical history.
Use food-specific IgE blood testing only for suspected foods rather than indiscriminate panels.
Interpret positive IgE tests as sensitization, not automatic proof of clinical allergy.
Avoid commercial food-IgG or IgG4 “sensitivity” panels.
Avoid hair analysis, electrodermal testing, applied kinesiology, and similar unvalidated allergy tests.
Use supervised oral food challenge when diagnosis remains uncertain and the expected benefit justifies the risk.
Perform food challenges in a setting equipped to treat anaphylaxis.
Never conduct a home food challenge after a previous serious reaction unless explicitly directed by a specialist.
Consider supervised graded medication challenge when allergy probability is low.
Use skin testing for penicillin allergy when clinically appropriate.
Follow negative penicillin skin testing with a supervised oral challenge when indicated.
Consider direct oral amoxicillin challenge for selected low-risk histories under an established clinical protocol.
Refer complex antibiotic reactions to an allergy specialist for evaluation and possible de-labeling.
Use drug desensitization only when the medicine is essential and no adequate alternative exists.
Conduct desensitization under specialist supervision in a monitored setting.
Recognize that desensitization creates temporary tolerance and may need repeating after treatment interruption.
Do not challenge or desensitize patients with certain severe cutaneous adverse reactions unless a specialist determines otherwise.
Use patch testing for selected delayed contact reactions to medications or excipients.
Consider serum tryptase during a severe suspected anaphylactic event and a later baseline level when indicated.
Recognize that a normal tryptase result does not exclude food-induced anaphylaxis.

261–280: Food Avoidance, Nutrition, and Prevention

Avoid only foods supported by the history and appropriate testing.
Do not remove entire food groups without a nutritional replacement plan.
Consult a registered dietitian for multiple-food avoidance.
Monitor children with food restrictions for normal growth.
Monitor adults with extensive restrictions for unintentional weight loss.
Check for nutrient deficiencies when the diet is substantially limited.
Learn the legally required allergen terms on packaged-food labels.
Read the complete label every time because formulations can change.
Verify ingredients when switching package size, flavor, or manufacturer.
Contact the manufacturer when an ingredient source is unclear.
Ask restaurants about ingredients and cross-contact procedures.
Inform restaurant staff clearly that the condition is a medically important allergy.
Avoid buffets and shared serving utensils when cross-contact risk is high.
Use separate utensils and preparation surfaces at home when medically necessary.
Wash surfaces with soap and water rather than relying only on hand sanitizer to remove food proteins.
Wash hands with soap and water after handling the allergen.
Keep safe snacks available during travel, school, and work.
Carry epinephrine whenever prescribed.
Keep epinephrine at the recommended storage temperature and replace expired or damaged devices.
Ask an allergist whether an approved food-allergy immunotherapy option is appropriate; do not attempt home desensitization.

281–290: Medicines and Excipients

Maintain one precise medication-allergy list containing the drug, formulation, date, symptoms, timing, and severity.
Separate true allergies from side effects and intolerances in the medical record.
Remove inaccurate allergy labels after a properly supervised negative evaluation.
Ask a pharmacist to compare active and inactive ingredients across formulations.
Check the current package insert or the U.S. National Library of Medicine’s DailyMed labeling for excipients.
Do not assume that brand-name, generic, liquid, tablet, capsule, and injectable versions have identical excipients.
Investigate a specific excipient only when reactions recur with products sharing that ingredient.
Consider substances such as PEG, polysorbate, gelatin, carboxymethylcellulose, lactose, dyes, or preservatives only in the context of the reaction history.
Recognize that highly refined pharmaceutical lactose generally contains little milk protein, but contamination concerns may matter in exceptionally milk-allergic patients.
Avoid automatically attributing symptoms to every chemical-sounding ingredient; many excipients have different structures and do not cross-react.

291–300: Safer Formulation and Coordinated Care

Select a commercially available dye-free, preservative-free, or flavor-free formulation when medically appropriate.
Use a different dosage form only after confirming that its dose, absorption, and ingredients are suitable.
Consider a reputable compounding pharmacy when a necessary medication lacks a tolerable commercial formulation.
Obtain a precise prescription identifying the excipient that must be excluded.
Confirm that a compounded product does not contain hidden ingredients from capsules, flavorings, suspending agents, or source materials.
Recognize that compounded medicines are not automatically safer and may have potency, sterility, or stability limitations.
Coordinate decisions among the prescriber, allergist, pharmacist, dietitian, and relevant specialists.
Wear medical identification for confirmed severe food or medication allergies.
Carry a written emergency action plan and teach family, school, or coworkers how to use it.
Review allergy labels, nutritional status, emergency medicines, and tolerated alternatives at least periodically.

Particularly Important Cautions

Epinephrine is first-line treatment for anaphylaxis. Antihistamines may reduce itching or hives but do not reliably reverse airway obstruction or shock.
Avoid broad “allergy panels.” Testing many foods without a compatible history frequently produces false-positive or clinically irrelevant results.
Do not stop an essential prescription abruptly unless an acute serious reaction is occurring or a clinician directs discontinuation. Some drugs—including corticosteroids, benzodiazepines, antiseizure medicines, beta-blockers, and certain psychiatric medications—can cause dangerous withdrawal or rebound effects.
Severe delayed drug reactions such as Stevens–Johnson syndrome/toxic epidermal necrolysis, DRESS, or organ injury generally require permanent avoidance and specialist documentation rather than routine rechallenge.
A patient reacting to many unrelated products may still have a genuine illness, but the evaluation should consider multiple mechanisms rather than presuming one universal excipient allergy.
Restrictive diets and extensive medication avoidance can themselves cause harm, including malnutrition, undertreated infection, loss of first-line antibiotics, and increased healthcare risks.

Full References

1. Shaker MS, Wallace DV, Golden DBK, et al. Anaphylaxis—a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation analysis. Journal of Allergy and Clinical Immunology. 2020;145(4):1082–1123. doi:10.1016/j.jaci.2020.01.017.

2. Golden DBK, Wang J, Waserman S, et al. Anaphylaxis: A 2023 practice parameter update. Annals of Allergy, Asthma & Immunology. 2024;132(2):124–176. doi:10.1016/j.anai.2023.09.015.

3. Sicherer SH, Sampson HA. Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management. Journal of Allergy and Clinical Immunology. 2018;141(1):41–58. doi:10.1016/j.jaci.2017.11.003.

4. Boyce JA, Assa’ad A, Burks AW, et al. Guidelines for the diagnosis and management of food allergy in the United States: Report of the NIAID-sponsored expert panel. Journal of Allergy and Clinical Immunology. 2010;126(6 Suppl):S1–S58. doi:10.1016/j.jaci.2010.10.007.

5. Togias A, Cooper SF, Acebal ML, et al. Addendum guidelines for the prevention of peanut allergy in the United States: Report of the NIAID-sponsored expert panel. Journal of Allergy and Clinical Immunology. 2017;139(1):29–44. doi:10.1016/j.jaci.2016.10.010.

6. Muraro A, Worm M, Alviani C, et al. EAACI guidelines: Anaphylaxis (2021 update). Allergy. 2022;77(2):357–377. doi:10.1111/all.15032.

7. Santos AF, Riggioni C, Agache I, et al. EAACI guidelines on the diagnosis of IgE-mediated food allergy. Allergy. 2023;78(12):3057–3076. doi:10.1111/all.15902.

8. Bird JA, Leonard S, Groetch M, et al. Conducting an oral food challenge: An update to the 2009 Adverse Reactions to Foods Committee work group report. Journal of Allergy and Clinical Immunology: In Practice. 2020;8(1):75–90.e17. doi:10.1016/j.jaip.2019.09.029.

9. Greenhawt M, Shaker M, Wang J, et al. Peanut allergy diagnosis: A 2020 practice parameter update, systematic review, and GRADE analysis. Journal of Allergy and Clinical Immunology. 2020;146(6):1302–1334. doi:10.1016/j.jaci.2020.07.031.

10. Joint Task Force on Practice Parameters; Khan DA, Banerji A, Blumenthal KG, et al. Drug allergy: A 2022 practice parameter update. Journal of Allergy and Clinical Immunology. 2022;150(6):1333–1393. doi:10.1016/j.jaci.2022.08.028.

11. Stone CA Jr, Liu Y, Relling MV, et al. Immediate hypersensitivity to polyethylene glycols and polysorbates: More common than we have recognized. Journal of Allergy and Clinical Immunology: In Practice. 2019;7(5):1533–1540.e8. doi:10.1016/j.jaip.2018.12.003.

12. Bruusgaard-Mouritsen MA, Johansen JD, Garvey LH. Clinical manifestations and impact on daily life of allergy to polyethylene glycol in adults: A case series. Clinical & Experimental Allergy. 2021;51(3):463–470. doi:10.1111/cea.13822.

13. Caballero ML, Quirce S. Excipients as potential agents of anaphylaxis in vaccines, drugs, and cosmetics: Facts and fiction. Journal of Investigational Allergology and Clinical Immunology. 2020;30(2):93–100. doi:10.18176/jiaci.0476.

14. Stone CA Jr, Commins SP, Choudhary S, et al. Anaphylaxis after vaccination in a pediatric patient: Further implicating alpha-gal allergy. Journal of Allergy and Clinical Immunology: In Practice. 2019;7(1):322–324.e2. doi:10.1016/j.jaip.2018.06.005.

15. Commins SP. Diagnosis and management of alpha-gal syndrome: Lessons from 2,500 patients. Expert Review of Clinical Immunology. 2020;16(7):667–677. doi:10.1080/1744666X.2020.1782745.

16. Leonard MM, Sapone A, Catassi C, Fasano A. Celiac disease and nonceliac gluten sensitivity: A review. JAMA. 2017;318(7):647–656. doi:10.1001/jama.2017.9730.

17. Rubio-Tapia A, Hill ID, Semrad C, Kelly CP, Greer KB, Limketkai BN, Lebwohl B. American College of Gastroenterology guidelines update: Diagnosis and management of celiac disease. American Journal of Gastroenterology. 2023;118(1):59–76. doi:10.14309/ajg.0000000000002075.

18. U.S. Food and Drug Administration. Food Allergies: What You Need to Know. FDA consumer guidance. Available at: https://www.fda.gov/food/buy-store-serve-safe-food/food-allergies-what-you-need-know (opens in new tab)

19. U.S. Food and Drug Administration. Inactive Ingredient Database. Available at: https://www.accessdata.fda.gov/scripts/cder/iig/ (opens in new tab)

20. U.S. National Library of Medicine. DailyMed: FDA Label Information. Available at: https://dailymed.nlm.nih.gov/dailymed/ (opens in new tab)

21. U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers. Available at: https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers (opens in new tab)

22. U.S. Food and Drug Administration. FDA Approves First Oral Immunotherapy for Treatment of Peanut Allergy. Available at: https://www.fda.gov/news-events/press-announcements/fda-approves-first-drug-treatment-peanut-allergy-children (opens in new tab)

23. Sicherer SH, Mahr T; American Academy of Pediatrics Section on Allergy and Immunology. Management of food allergy in the school setting. Pediatrics. 2010;126(6):1232–1239. doi:10.1542/peds.2010-2575.

24. America’s Poison Centers. Poison Help. Telephone: 1-800-222-1222. Available at: https://www.poisonhelp.org/ (opens in new tab)